
- Winrate
- 49.8%
- Pick rate
- 9.4%
Trojitý lektvar Nejlepší šampioni
- Patch
- 26.23
- Hry s runou
- 59 666
- Lajna
- Všechny linie
- Tier
- Všechny tiery
- Poslední aktualizace
- 20. 11. 2026 UTC
- Autor
- Dakota Chinnick
- Metodika
- Metodika dat
Po dosažení 6. úrovně získáš Elixír síly.
Po dosažení 9. úrovně získáš Elixír dovednosti.
Nejlepší šampioni pro Trojitý lektvar
Patch 26.23 · Všechny rankyS runou Trojitý lektvar vede Nunu a Willump s úspěšností 56.8%; v tomto patchi ji berou šampioni: 110.
- 1
Nunu a WillumpMid56.8% s runou+2.5 vs průměr šampiona285 her - 2
Miss FortuneADC54.9% s runou+2.9 vs průměr šampiona577 her - 3
SylasJungle54.5% s runou+4.2 vs průměr šampiona343 her
Řazeno podle úspěšnosti s runou, upraveno podle velikosti vzorku: malé vzorky se přitahují k průměru runy, takže šampion s pár desítkami šťastných her nemůže vést žebříček. Aby byl šampion označen za nejlepšího, potřebuje 200+ her.
Všichni šampioni, kteří berou Trojitý lektvar
Počet kombinací šampiona a linie s 30+ hrami: 149. Hledej šampiona nebo filtruj podle linie a tieru.
Pořadí | Šampion | Lajna | Tier | Úspěšnost | Δ WR | Využití | Zápasy | Nejlepší build run |
|---|---|---|---|---|---|---|---|---|
| 1 | Mid | S | 59.8% | +9.3 | 12.0% | 199 | — | |
| 2 | Top | S | 60.7% | +9.0 | 8.3% | 168 | — | |
| 3 | Mid | S | 56.8% | +2.5 | 77.0% | 285 | — | |
| 4 | ADC | S | 54.9% | +2.9 | 11.8% | 577 | ||
| 5 | Top | S | 59.7% | +10.6 | 4.4% | 139 | — | |
| 6 | Jungle | S | 60.0% | +7.1 | 18.3% | 130 | — | |
| 7 | Jungle | S | 57.7% | +6.4 | 4.6% | 189 | ||
| 8 | Mid | S | 62.1% | +9.5 | 11.6% | 87 | — | |
| 9 | Mid | S | 61.9% | +9.4 | 1.2% | 84 | — | |
| 10 | Jungle | S | 54.5% | +4.2 | 8.6% | 343 | — | |
| 11 | Mid | S | 59.5% | +6.3 | 4.0% | 84 | — | |
| 12 | Jungle | S | 53.1% | -0.2 | 18.5% | 401 | — | |
| 13 | Jungle | S | 55.6% | +3.7 | 6.1% | 142 | ||
| 14 | ADC | S | 52.7% | +3.1 | 8.4% | 488 | — | |
| 15 | ADC | S | 57.0% | +5.4 | 4.1% | 93 | — | |
| 16 | Top | S | 55.7% | +5.7 | 7.2% | 115 | — | |
| 17 | Top | S | 64.7% | +1.2 | 35.4% | 34 | — | |
| 18 | Jungle | S | 53.6% | +4.5 | 6.1% | 192 | — | |
| 19 | Jungle | S | 62.5% | +13.8 | 0.9% | 40 | — | |
| 20 | Top | S | 52.6% | -1.3 | 75.7% | 333 | ||
| 21 | ADC | S | 57.1% | +6.1 | 3.0% | 70 | — | |
| 22 | Top | S | 56.4% | +7.5 | 19.7% | 78 | — | |
| 23 | Support | S | 61.5% | +10.5 | 0.9% | 39 | — | |
| 24 | ADC | A | 51.8% | -0.1 | 29.9% | 558 | — | |
| 25 | Jungle | A | 54.6% | +5.4 | 5.6% | 108 | — | |
| 26 | Jungle | A | 51.5% | +0.8 | 69.0% | 993 | ||
| 27 | Jungle | A | 52.9% | +3.1 | 5.8% | 204 | — | |
| 28 | Jungle | A | 54.5% | +5.6 | 6.8% | 112 | — | |
| 29 | ADC | A | 51.5% | -0.1 | 13.8% | 796 | ||
| 30 | Top | A | 60.5% | +11.1 | 2.3% | 38 | — | |
| 31 | ADC | A | 59.5% | +6.3 | 6.4% | 42 | — | |
| 32 | Mid | A | 58.3% | +10.3 | 1.2% | 48 | — | |
| 33 | Mid | A | 51.9% | +2.4 | 19.0% | 360 | — | |
| 34 | ADC | A | 54.3% | +3.9 | 81.4% | 105 | ||
| 35 | Support | A | 51.9% | -0.3 | 24.4% | 366 | — | |
| 36 | ADC | A | 57.1% | +9.8 | 3.1% | 56 | ||
| 37 | Top | A | 61.3% | +13.8 | 1.4% | 31 | — | |
| 38 | Mid | A | 58.5% | +5.9 | 1.6% | 41 | — | |
| 39 | Jungle | A | 52.2% | +2.9 | 7.5% | 226 | — | |
| 40 | ADC | A | 53.4% | +0.0 | 23.3% | 116 | — | |
| 41 | ADC | A | 51.8% | +3.6 | 59.8% | 305 | — | |
| 42 | Top | A | 52.1% | +2.0 | 16.0% | 219 | ||
| 43 | ADC | A | 50.9% | -0.9 | 47.4% | 1 638 | — | |
| 44 | Mid | A | 53.8% | +3.1 | 4.2% | 91 | — | |
| 45 | Mid | A | 51.2% | -0.3 | 12.3% | 576 | — | |
| 46 | Support | A | 59.4% | +9.0 | 4.3% | 32 | — | |
| 47 | Top | A | 59.4% | +13.3 | 14.0% | 32 | — | |
| 48 | ADC | A | 58.3% | +2.1 | 6.5% | 36 | — | |
| 49 | ADC | A | 58.3% | +3.1 | 25.2% | 36 | — | |
| 50 | Jungle | A | 52.0% | +2.0 | 35.3% | 175 | — | |
| 51 | Support | A | 58.1% | +9.6 | 2.4% | 31 | — | |
| 52 | Jungle | A | 51.4% | +2.6 | 7.6% | 296 | — | |
| 53 | Jungle | A | 51.6% | +0.9 | 55.8% | 225 | — | |
| 54 | ADC | A | 50.6% | +0.9 | 21.7% | 2 680 | — | |
| 55 | ADC | A | 54.0% | -0.5 | 13.5% | 63 | — | |
| 56 | Jungle | A | 52.8% | +3.3 | 1.8% | 89 | — | |
| 57 | Top | A | 50.6% | -0.2 | 65.6% | 1 934 | — | |
| 58 | Mid | A | 50.5% | +1.1 | 64.5% | 2 592 | ||
| 59 | Top | A | 52.0% | +2.2 | 6.2% | 127 | — | |
| 60 | Mid | A | 55.9% | +4.6 | 2.3% | 34 | — | |
| 61 | Support | B | 55.0% | +7.3 | 9.0% | 40 | — | |
| 62 | Mid | B | 51.5% | +1.0 | 8.6% | 171 | — | |
| 63 | Top | B | 54.3% | +4.4 | 1.5% | 35 | — | |
| 64 | Top | B | 50.9% | -1.0 | 17.6% | 230 | — | |
| 65 | ADC | B | 52.8% | -0.6 | 3.8% | 53 | — | |
| 66 | Jungle | B | 52.2% | +1.4 | 7.1% | 69 | — | |
| 67 | Jungle | B | 52.2% | +4.3 | 6.6% | 69 | — | |
| 68 | ADC | B | 52.2% | +2.8 | 43.7% | 69 | — | |
| 69 | ADC | B | 50.3% | +1.0 | 40.7% | 1 540 | — | |
| 70 | ADC | B | 50.4% | +0.0 | 17.7% | 760 | ||
| 71 | Support | B | 51.5% | +3.2 | 1.9% | 97 | — | |
| 72 | Mid | B | 51.3% | +3.7 | 22.5% | 119 | ||
| 73 | Mid | B | 51.2% | +2.9 | 3.2% | 123 | — | |
| 74 | Mid | B | 53.3% | +4.9 | 2.5% | 30 | — | |
| 75 | ADC | B | 53.1% | -2.2 | 37.6% | 32 | — | |
| 76 | Support | B | 52.9% | +3.4 | 1.5% | 34 | — | |
| 77 | Top | B | 52.8% | +0.5 | 33.0% | 36 | — | |
| 78 | Jungle | B | 52.2% | +3.0 | 2.1% | 46 | — | |
| 79 | Mid | B | 51.7% | +2.5 | 3.1% | 58 | — | |
| 80 | Mid | B | 51.6% | +5.5 | 6.0% | 64 | — | |
| 81 | Top | B | 51.2% | +0.7 | 2.6% | 82 | — | |
| 82 | Top | B | 50.2% | -0.2 | 6.8% | 309 | — | |
| 83 | ADC | B | 50.5% | +1.3 | 3.6% | 97 | — | |
| 84 | Jungle | B | 50.5% | +3.5 | 14.7% | 97 | — | |
| 85 | Jungle | B | 49.9% | -1.1 | 16.6% | 397 | — | |
| 86 | Top | B | 50.0% | -2.9 | 55.8% | 58 | — | |
| 87 | Support | B | 50.0% | -2.2 | 1.1% | 54 | — | |
| 88 | ADC | B | 49.8% | -0.7 | 54.2% | 2 368 | ||
| 89 | Mid | B | 50.0% | +1.3 | 2.2% | 40 | — | |
| 90 | ADC | B | 49.5% | -1.7 | 7.4% | 109 | — | |
| 91 | Jungle | B | 49.2% | +0.6 | 0.7% | 63 | — | |
| 92 | Support | B | 49.2% | -1.8 | 1.7% | 63 | — | |
| 93 | ADC | B | 49.6% | -2.3 | 24.7% | 552 | — | |
| 94 | Top | B | 49.2% | +0.1 | 8.6% | 61 | — | |
| 95 | Mid | B | 49.2% | +2.5 | 44.4% | 59 | — | |
| 96 | Top | B | 48.9% | -2.4 | 1.2% | 45 | — | |
| 97 | Top | B | 49.4% | +2.3 | 11.5% | 162 | — | |
| 98 | ADC | B | 48.8% | -0.0 | 5.3% | 80 | — | |
| 99 | Top | B | 49.3% | -0.2 | 22.7% | 300 | — | |
| 100 | Mid | B | 47.9% | -2.5 | 2.9% | 48 | — | |
| 101 | Support | B | 49.0% | +0.8 | 2.2% | 149 | — | |
| 102 | Top | B | 48.8% | -1.6 | 4.5% | 125 | — | |
| 103 | ADC | B | 49.4% | -0.2 | 33.9% | 1 053 | ||
| 104 | Jungle | B | 48.5% | -1.2 | 4.2% | 97 | — | |
| 105 | Top | B | 47.4% | +4.5 | 19.9% | 57 | ||
| 106 | Top | B | 46.9% | -4.8 | 2.3% | 49 | — | |
| 107 | Support | B | 46.3% | -5.2 | 1.8% | 41 | — | |
| 108 | Mid | B | 46.2% | -4.8 | 1.3% | 39 | — | |
| 109 | ADC | B | 49.1% | -0.5 | 4.2% | 505 | — | |
| 110 | Top | B | 47.6% | -1.4 | 5.9% | 82 | — | |
| 111 | Support | B | 45.0% | +3.5 | 42.6% | 40 | ||
| 112 | Mid | C | 44.1% | -2.6 | 10.2% | 34 | — | |
| 113 | Jungle | C | 49.0% | -1.2 | 28.6% | 935 | — | |
| 114 | ADC | C | 49.1% | -0.9 | 40.3% | 1 942 | — | |
| 115 | Top | C | 46.2% | -2.5 | 2.6% | 65 | — | |
| 116 | ADC | C | 48.3% | -2.0 | 43.5% | 230 | — | |
| 117 | Jungle | C | 41.9% | -8.8 | 1.6% | 31 | — | |
| 118 | ADC | C | 48.8% | -1.6 | 48.1% | 1 238 | — | |
| 119 | ADC | C | 41.2% | -7.4 | 4.5% | 34 | — | |
| 120 | Jungle | C | 41.2% | -4.0 | 23.3% | 34 | — | |
| 121 | Jungle | C | 48.6% | +0.3 | 83.5% | 950 | ||
| 122 | Jungle | C | 43.1% | -9.4 | 2.7% | 51 | — | |
| 123 | Mid | C | 45.1% | -5.0 | 17.4% | 82 | ||
| 124 | Mid | C | 45.1% | -4.0 | 29.0% | 82 | ||
| 125 | Jungle | C | 47.6% | -1.5 | 36.9% | 246 | — | |
| 126 | Jungle | C | 48.6% | +0.1 | 68.2% | 2 109 | ||
| 127 | ADC | C | 45.8% | -4.7 | 2.9% | 107 | — | |
| 128 | ADC | C | 48.6% | -0.6 | 31.8% | 2 186 | ||
| 129 | Top | C | 42.3% | -4.7 | 3.9% | 52 | — | |
| 130 | Mid | C | 48.6% | -1.5 | 52.8% | 2 661 | — | |
| 131 | Mid | C | 46.4% | -1.6 | 32.3% | 151 | ||
| 132 | Support | C | 40.0% | -8.1 | 1.2% | 40 | — | |
| 133 | Mid | C | 48.1% | -1.0 | 57.9% | 867 | — | |
| 134 | Jungle | C | 48.2% | +0.0 | 93.9% | 3 831 | — | |
| 135 | Support | C | 38.8% | -12.6 | 1.0% | 49 | — | |
| 136 | Mid | C | 43.3% | +0.7 | 14.2% | 97 | — | |
| 137 | Support | C | 36.6% | -14.7 | 0.9% | 41 | — | |
| 138 | Mid | C | 41.1% | -8.2 | 1.6% | 73 | — | |
| 139 | Jungle | C | 38.2% | -13.0 | 3.4% | 55 | — | |
| 140 | Support | C | 35.6% | -16.0 | 1.7% | 45 | — | |
| 141 | Top | C | 47.5% | -0.2 | 40.6% | 1 550 | ||
| 142 | Mid | C | 38.7% | +0.4 | 44.0% | 62 | — | |
| 143 | ADC | C | 47.5% | +0.6 | 10.7% | 1 480 | — | |
| 144 | Jungle | C | 44.2% | -6.3 | 19.6% | 197 | — | |
| 145 | ADC | C | 34.5% | -11.2 | 17.9% | 58 | — | |
| 146 | Top | C | 33.9% | -13.6 | 1.5% | 56 | — | |
| 147 | Top | C | 44.4% | -5.7 | 10.4% | 277 | — | |
| 148 | Support | C | 30.8% | -8.1 | 25.2% | 52 | — | |
| 149 | Jungle | C | 45.5% | +0.5 | 96.1% | 2 542 | ||
Šampioni, kteří téměř vždy berou Trojitý lektvar
Jayce bere Trojitý lektvar v 96% svých her. Vysoké zastoupení znamená, že runa je pro toho šampiona standard.
Tiery šampionů pro Trojitý lektvar
Všichni šampioni, kteří berou Trojitý lektvar, seskupení podle winratu s runou upraveného podle velikosti vzorku (S = horních 15 %).
Získej výhodu pro vítězství
Overlaye v reálném čase, automatické sledování zápasů a exkluzivní nástroje — vše, co potřebuješ k posunu výš, zdarma na tvém PC.
- Overlaye ve hře
- Automatické sledování zápasů
- Nástroje exkluzivně pro desktop
Pomoz nám udržet přesnost! Pokud si všimneš nesprávných statistik, chybějících dat nebo jiných problémů, tvoje zpětná vazba přímo zlepšuje kvalitu našich dat pro celou komunitu.
FAQ: nejlepší šampioni pro Trojitý lektvar – patch 26.23
Kteří šampioni jsou nejlepší pro Trojitý lektvar v patchi 26.23?
Podle úspěšnosti s Trojitý lektvar: Nunu a Willump (56.8%), Miss Fortune (54.9%), Sylas (54.5%). V tomto patchi ji berou šampioni: 110.
Kteří šampioni používají Trojitý lektvar nejčastěji?
Nejvíc her s Trojitý lektvar: Qiyana (3 831), Kai'Sa (2 680), Syndra (2 661).
Na které linii se hraje Trojitý lektvar?
Trojitý lektvar se hraje většinou na linii ADC (38.5% her).
Který šampion bere Trojitý lektvar nejkonzistentněji?
Jayce bere Trojitý lektvar v 96% svých her, což je nejvíc ze šampionů, kteří ji používají (celkem 110).
